Park Ha Biological Technology Co., Ltd. (BYAH)
↓ Download CSV- Sector Manufacturing
- Incorporated F4
- Fiscal year ends Oct 31
In fiscal 2025, Park Ha Biological Technology Co., Ltd. reported revenue of $2.52M, up 6.0% from the prior year. The company ran a net loss, with a net margin of -965.0% and a gross margin of 94.4%. It held $5.95M in total assets against $1.96M in total liabilities.
Key ratios (FY2025)
94.4%
Gross margin
-956.5%
Operating margin
-965.0%
Net margin
-609.9%
Return on equity
+6.0%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $2.52M | $2.38M | $2.46M | $1.92M | — |
| Cost of Revenue | $142.5K | $195.3K | $311.0K | $509.2K | — |
| Gross Profit | $2.38M | $2.19M | $2.15M | $1.41M | — |
| Operating Income | -$24.15M | $793.7K | $1.18M | $197.0K | — |
| Net Income | -$24.36M | $478.6K | $852.0K | $191.3K | — |
| EPS (Diluted) | $-41.38 | $0.96 | $1.70 | $0.01 | — |
| Total Assets | $5.95M | $3.08M | $2.26M | — | — |
| Total Liabilities | $1.96M | $1.58M | $1.25M | — | — |
| Shareholders' Equity | $3.99M | $1.51M | $1.01M | $150.3K | -$578.2K |
| Cash & Equivalents | $3.79M | $547.5K | $1.03M | — | — |
| Operating Cash Flow | $85.9K | $960.5K | $126.5K | $1.44M | — |
| Capital Expenditures | $88.8K | $85.6K | $22.7K | $11.9K | — |
| Shares Outstanding | 588.9K | 500.0K | 500.0K | 25.00M | — |